Zoetis Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Zoetis Inc.
- Ownership
- Public
- Status
- Active
- SIC code
- 2834 — Pharmaceutical Preparations
- Headquarters city
- Parsippany
- Headquarters state / province
- New Jersey
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- ZTS
- Primary stock exchange
- NYSE
Identifiers
- SEC CIK
- 0001555280
- EIN
- 46-0696167
Board of directors
-
Antoinette Renee Leatherberry · DirectorSince 2023
-
Frank A. Damelio · DirectorSince 2023
-
Gavin Hattersley · DirectorSince 2024
-
Gregory Norden · DirectorSince 2023
-
Khosla Sanjay · DirectorSince 2023
-
Kristin C. Peck · Director · Chief Executive OfficerSince 2023
-
Linda Rhodes · DirectorSince 2023
-
Louise M. Parent · DirectorSince 2023
-
Mark Stetter · DirectorSince 2025
-
Michael B. Mccallister · DirectorSince 2023
-
Paul Bisaro · DirectorSince 2023
-
Robert W. Scully · DirectorSince 2023
-
Stephanie Tilenius · DirectorSince 2025
-
Vanessa Broadhurst · DirectorSince 2023
-
Willie M. Reed · DirectorSince 2023
Chief executives
Kristin C. Peck
· Chief Executive Officer
Dates unknown
Director election results
Annual meeting of May 20, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
92.2%
-
93.3%
-
94.8%
-
95.1%
-
96.2%
-
96.3%
-
97.2%
-
98.6%
-
99.0%
-
99.1%
-
99.3%
Board connections
10 of this board's directors also sit on 16 other boards.
- via Michael B. Mccallister
- via Kristin C. Peck
- via Robert W. Scully
- via Antoinette Renee Leatherberry
- via Louise M. Parent
- via Michael B. Mccallister
- via Frank A. Damelio
- via Frank A. Damelio
- via Robert W. Scully
- via Gavin Hattersley
- via Gavin Hattersley
- via Paul Bisaro
- via Gregory Norden
- via Gregory Norden
- via Stephanie Tilenius
- via Frank A. Damelio
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $886,384
- 3 purchases by 3 insiders
- Sold, last 12 months
- $2,540,972
- 2 sales by 1 insider
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 7, 2026 | Frank A. Damelio Director | Gift | −6,650 | — | — |
| Jun 10, 2026 | Michael B. Mccallister Director | Gift | −1,209 | — | — |
| May 21, 2026 | Mark Stetter Director | Option exercise | +1,572 | — | — |
| May 20, 2026 | Louise M. Parent Director | Option exercise | +1,944 | — | — |
| May 20, 2026 | Louise M. Parent Director | Option exercise | +10,186 | — | — |
| May 13, 2026 | Frank A. Damelio Director | Open-market purchase | +6,650 | $75.39 | $501,344 |
| May 13, 2026 | Paul Bisaro Director | Open-market purchase | +2,000 | $75.88 | $151,760 |
| May 11, 2026 | Michael B. Mccallister Director | Open-market purchase | +3,000 | $77.76 | $233,280 |
| Apr 30, 2026 | Esch Kevin Officer (Executive Vice President) | Option exercise | +259 | — | — |
| Apr 30, 2026 | Esch Kevin Officer (Executive Vice President) | Shares withheld for tax | −75 | $114.97 | $8,623 |
| Mar 31, 2026 | Sarbaugh Keith Officer (Executive Vice President) | Option exercise | +1,528 | — | — |
| Mar 31, 2026 | Sarbaugh Keith Officer (Executive Vice President) | Shares withheld for tax | −524 | $118.21 | $61,942 |
| Mar 9, 2026 | Gregory Norden Director | Gift | −1,213 | — | — |
| Feb 19, 2026 | Michael B. Mccallister Director | Option exercise | +1,619 | — | — |
| Feb 19, 2026 | Gregory Norden Director | Option exercise | +1,619 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.